Clinical trial
Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer
NCT07565818 is registered in ClinicalTrials.gov with Yunnan Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer
- Lead sponsor
- Yunnan Cancer Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 4, 2025
- Completion date
- December 31, 2026
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer